Symmetry Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Symmetry Partners’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,151	Closed	-$244K	–	564
2023 Q3	$244K	Hold	1,151	–	–	0.01%	469
2023 Q2	$222K	Hold	1,151	–	–	0.01%	541
2023 Q1	$233K	Buy	+1,151	New	+$185K	0.01%	506
2021 Q1	–	Sell	-1,149	Closed	-$201K	–	656
2020 Q4	$201K	Buy	1,149 +14	+1%	+$2.61K	0.02%	589
2020 Q3	$222K	Buy	+1,135	New	+$190K	0.02%	553

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Symmetry Partners's SGEN Position: Q4 2023 in Review

Symmetry Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,151 shares — an estimated $244K sold.

Symmetry Partners first reported a position in SGEN in Q3 2020 and held it in 5 quarters. The position peaked at $244K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Symmetry Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Symmetry Partners sold 1,151 Seagen Inc. Common Stock shares in Q4 2023, an estimated $244K.
Symmetry Partners first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Symmetry Partners's Seagen Inc. Common Stock position peaked at $244K in Q3 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Symmetry Partners's 13F filing for Q4 2023, filed 2 Jan 2024.